Arbutus Biopharma Corporation DPO Ratio 2011-2026 | ABUS

Annual DPO Ratio Arbutus Biopharma Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	23	15.2	20.1	11.6	19.2	18.5	19.3	20.7	16.2	-

All numbers in USD currency

Maximum	Minimum	Average
23	11.6	18.2

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
Aurinia Pharmaceuticals AUPH	47.5	$ 14.01	-3.78 %	$ 1.88 B	Canada
Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Amphastar Pharmaceuticals AMPH	31.7	$ 19.32	0.47 %	$ 903 M	USA
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	4.39 K	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
CollPlant Biotechnologies Ltd. CLGN	72.6	$ 0.68	12.29 %	$ 7.79 M	Israel
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Exelixis EXEL	148	$ 41.57	0.39 %	$ 11.3 B	USA
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	186	$ 2.61	-0.76 %	$ 16.4 M	USA
BioDelivery Sciences International BDSI	96.3	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	915	-	0.49 %	$ 251 B	Cayman-islands
Halozyme Therapeutics HALO	24.8	$ 62.11	-1.19 %	$ 7.44 B	USA
AIkido Pharma AIKI	32.8 K	-	1.93 %	$ 17.4 M	USA
Brickell Biotech BBI	105	-	-5.38 %	$ 6.06 M	USA